Search research articles
Contact Us
Filters
Showing results (81-90 of 128) with videos related to
Page
of 13
Sort By:
Cancer Research
|
January 20, 2007
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells
Yoko Tabe, Linhua Jin, Yuko Tsutsumi-Ishii, et al.
RSC Advances
|
April 15, 2022
X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution
Marcin Ziemniak, Sylwia Pawlędzio, Anna Zawadzka-Kaźmierczuk, et al.
Drug Metabolism and Pharmacokinetics
|
December 27, 2007
In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs
Ai Tamura, Yuko Onishi, Ran An, et al.
Materials (Basel, Switzerland)
|
March 28, 2024
Structure, Antioxidant Activity and Antimicrobial Study of Light Lanthanide Complexes with p-Coumaric Acid
Grzegorz Świderski, Ewelina Gołębiewska, Natalia Kowalczyk, et al.
Cancer
|
June 22, 2011
Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells
Vlad C Sandulache, Thomas J Ow, Curtis R Pickering, et al.
Neoplasia (New York, N.Y.)
|
January 30, 2013
Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells
Jeannine Garnett, Vaibhav Chumbalkar, Brian Vaillant, et al.
Investigational New Drugs
|
October 31, 2006
The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells
Tracy A Brooks, Kieran L O'Loughlin, Hans Minderman, et al.
Cancer Chemotherapy and Pharmacology
|
December 30, 2006
WP760, a melanoma selective drug
Mingzhong Zheng, Waldemar Priebe, Eugene T Walch, et al.
Cancer Biology & Therapy
|
May 5, 2012
Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells
Karolina Swiatek-Machado, Jakub Mieczkowski, Aleksandra Ellert-Miklaszewska, et al.
International Journal of Cancer
|
July 28, 2011
The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models
Mustafa Aziz Hatiboglu, Ling-Yuan Kong, Jun Wei, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 128) with videos related to
Sort By:
Page
of 13
Cancer Research
|
January 20, 2007
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells
Yoko Tabe, Linhua Jin, Yuko Tsutsumi-Ishii, et al.
RSC Advances
|
April 15, 2022
X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution
Marcin Ziemniak, Sylwia Pawlędzio, Anna Zawadzka-Kaźmierczuk, et al.
Drug Metabolism and Pharmacokinetics
|
December 27, 2007
In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs
Ai Tamura, Yuko Onishi, Ran An, et al.
Materials (Basel, Switzerland)
|
March 28, 2024
Structure, Antioxidant Activity and Antimicrobial Study of Light Lanthanide Complexes with p-Coumaric Acid
Grzegorz Świderski, Ewelina Gołębiewska, Natalia Kowalczyk, et al.
Cancer
|
June 22, 2011
Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells
Vlad C Sandulache, Thomas J Ow, Curtis R Pickering, et al.
Neoplasia (New York, N.Y.)
|
January 30, 2013
Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells
Jeannine Garnett, Vaibhav Chumbalkar, Brian Vaillant, et al.
Investigational New Drugs
|
October 31, 2006
The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells
Tracy A Brooks, Kieran L O'Loughlin, Hans Minderman, et al.
Cancer Chemotherapy and Pharmacology
|
December 30, 2006
WP760, a melanoma selective drug
Mingzhong Zheng, Waldemar Priebe, Eugene T Walch, et al.
Cancer Biology & Therapy
|
May 5, 2012
Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells
Karolina Swiatek-Machado, Jakub Mieczkowski, Aleksandra Ellert-Miklaszewska, et al.
International Journal of Cancer
|
July 28, 2011
The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models
Mustafa Aziz Hatiboglu, Ling-Yuan Kong, Jun Wei, et al.
Page
of 13